VOTIS Subdermal Imaging Technologies

About:

VOTIS provides clinical decision assistance for foot ulcers syndrome and associated diseases.

Website: http://votis.net

Top Investors: MassChallenge, Italian Angels for Growth

Description:

VOTIS Subdermal Imaging Technologies help diabetics keep their feet through early screening for peripheral vascular disease and related complications. Early screening can offer new treatment options and help reduce incidents of amputation. Their device is non-invasive and contact-free, not based on radiation, and functionally consistent with the guidelines of the AHA, the American Diabetes Association, and other leading medical organizations. It will reduce healthcare costs for hospitals, clinics, and insurers.

Total Funding Amount:

$4.77M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Jerusalem, Yerushalayim, Israel

Founded Date:

2017-01-01

Contact Email:

merrillweber(AT)votis.net

Founders:

Andreas H. Hielscher, Merrill Weber

Number of Employees:

11-50

Last Funding Date:

2023-04-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai